A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2
Public ClinicalTrials.gov record NCT06039449. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study to Evaluate the Efficacy and Safety of VYD222 for Prevention of COVID-19 (CANOPY)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A study to investigate the prevention of COVID-19 with VYD222 in adults with immune compromise and in participants aged 12 years or older who are at risk of exposure to SARS-CoV-2
Study identification
- NCT ID
- NCT06039449
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 790 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 8, 2023 (Actual)
- Primary completion
- Nov 19, 2024 (Actual)
- Completion
- Nov 19, 2024 (Actual)
- Last update posted
- Dec 9, 2024
2023 – 2024
United States locations
- U.S. sites
- 18
- U.S. states
- 9
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| INVIVYD Investigative Site | Fullerton | California | 92835 | — |
| INVIVYD Investigative Site | Long Beach | California | 90806 | — |
| INVIVYD Investigative Site | Rolling Hills Estates | California | 90274 | — |
| INVIVYD Investigative Site | San Diego | California | 92103 | — |
| INVIVYD Investigative Site | Clearwater | Florida | 33756 | — |
| INVIVYD Investigative Site | Miami | Florida | 33186 | — |
| INVIVYD Investigative Site | St. Petersburg | Florida | 33705 | — |
| INVIVYD Investigative Site | Atlanta | Georgia | 30328 | — |
| INVIVYD Investigative Site | Hinesville | Georgia | 31313 | — |
| INVIVYD Investigative Site | Oak Brook | Illinois | 60523 | — |
| INVIVYD Investigative Site | Silver Spring | Maryland | 20904 | — |
| INVIVYD Investigative Site | Burlington | Massachusetts | 01803 | — |
| INVIVYD Investigative Site | Morrisville | North Carolina | 27560 | — |
| INVIVYD Investigative Site | Salisbury | North Carolina | 28144 | — |
| INVIVYD Investigative Site | Edmond | Oklahoma | 73013 | — |
| INVIVYD Investigative Site | Yukon | Oklahoma | 73099 | — |
| INVIVYD Investigative Site | Beaumont | Texas | 77706 | — |
| INVIVYD Investigative Site | Dallas | Texas | 75230 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06039449, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 9, 2024 · Synced Nov 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06039449 live on ClinicalTrials.gov.